Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MGI Tech is a leading global life science technology company specializing in the development of advanced genetic sequencing instruments, reagents, and laboratory automation systems. Founded as a subsidiary of BGI Group, the company has established itself as a primary competitor in the high-throughput sequencing market through its proprietary DNBSEQ technology. MGI's product portfolio includes a range of sequencers from portable devices to ultra-high-throughput platforms, alongside automated liquid handling systems and sample preparation kits. The company serves clinical, research, and industrial sectors, providing end-to-end solutions for genomics, proteomics, and cell biology applications worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MGI Grain.